Lifeboat Foundation

Is Director of the Division of Research, Innovation and Ventures (DRIVe — https://drive.hhs.gov/) at the Biomedical Advanced Research and Development Authority (https://aspr.hhs.gov/AboutASPR/ProgramOffices/BARDA/Pages/default.aspx), a U.S. Department of Health and Human Services (HHS) office responsible for the procurement and development of medical countermeasures, principally against bioterrorism, including chemical, biological, radiological and nuclear (CBRN) threats, as well as pandemic influenza and emerging diseases.

Dr. Patel is committed to advancing high-impact science, building new products, and launching collaborative programs and initiatives with public and private organizations to advance human health and wellness. As the DRIVe Director, Dr. Patel leads a dynamic team built to tackle complex national health security threats by rapidly developing and deploying innovative technologies and approaches that draw from a broad range of disciplines.

Continue reading “Dr. Sandeep Patel, Ph.D. — BARDA — Developing Effective Life-Saving Medical Countermeasures For All” »

Dr. Renee Wegrzyn, Ph.D. is the inaugural director of the Advanced Research Projects Agency for Health (ARPA-H — https://arpa-h.gov/), an agency that supports the development of high-impact research to drive biomedical and health breakthroughs to deliver transformative, sustainable, and equitable health solutions for everyone. ARPA-H’s mission focuses on leveraging research advances for real world impact.

Previously, Dr. Wegrzyn served as a vice president of business development at Ginkgo Bioworks and head of Innovation at Concentric by Ginkgo, where she focused on applying synthetic biology to outpace infectious diseases—including Covid-19—through biomanufacturing, vaccine innovation and biosurveillance of pathogens at scale.

Continue reading “Dr. Renee Wegrzyn, Ph.D. — ARPA-H — Transformative, Sustainable, Equitable Health Solutions For All” »

Students often sacrifice sleep to study for exams, but lack of sleep can negatively impact memory. Now, University of Groningen neuroscientist Robbert Havekes has found that sleep deprivation hinders recall, not retention of information. Havekes and his team used optogenetics and the drug roflumilast to make “hidden knowledge” obtained while sleep-deprived accessible again days later. Their findings were recently published in the journal Current Biology.

Havekes, associate professor of Neuroscience of Memory and Sleep at the University of Groningen, the Netherlands, and his team have extensively studied how sleep deprivation affects memory processes. “We previously focused on finding ways to support memory processes during a sleep deprivation episode”, says Havekes.

However, in his latest study, his team examined whether amnesia as a result of sleep deprivation was a direct result of information loss, or merely caused by difficulties retrieving information.

After six years of peace, the two tech giants are on course to butt heads again over the future of artificial intelligence.

Microsoft is about to go head-to-head with Google in a battle for the future of search. At a press event later today, Microsoft is widely expected to detail plans to bring OpenAI’s ChatGPT chatbot to its Bing search engine. Google has already tried to preempt the news, making a rushed announcement yesterday to introduce Bard, its rival to ChatGPT, and promising more details on its AI future in a press event on Wednesday.

The announcements put the two tech behemoths, known for their previous skirmishes with each other, on a collision course as they compete to define the next generation of search.

Continue reading “Microsoft will let companies create their own custom versions of ChatGPT, source says” »

Just 31 light-years away TechSpot is about to celebrate its 25th anniversary. TechSpot means tech analysis and advice you can trust. Why it matters: A team of international astronomers announced the discovery of an exoplanet that is both eerily similar and close to Earth on a galactic scale.

Saudi Arabian mining company Ma’aden, together with the King Abdullah University of Science and Technology (KAUST) Innovation Ventures Fund, are investing $6 million USD into Lithium Infinity (Lihytech). The KAUST startup’s battery-grade lithium will be a key component in driving the Kingdom of Saudi Arabia’s commitment to developing the entire value chain of electric vehicles (EVs).

Lihytech has patented a membrane-based lithium extraction technology developed by Professor Zhiping Lai at KAUST. The innovative technology can extract the alkali metal from sources such as seawater, brine, red mud and more. Based on KAUST research, the startup was funded through the KAUST Near Term Grand Challenge, a research translation program, and the technology is being developed on the campus.

This investment will take the technology from lab to commercial pilot scale. Ma’aden is leading the investment with $4 million and KAUST Innovation Ventures is investing $2 million. The University’s venture capital arm, KAUST Innovation Ventures, supports deep tech startups that look to offer solutions to pressing scientific and technological challenges, such as lithium extraction. Lihytech will use the infusion of capital to build a pilot facility at KAUST to extract lithium from the Red Sea and other in-Kingdom resources.

Blue Origin was selected to perform a Mars mission for NASA.

The U.S. space agency announced in a statement that it had contracted billionaire Jeff Bezos’ private space firm to launch a mission next year to study the magnetic field around Mars.

The “one-shot” process paves the path for cutting-edge 3D cell culture methods with biomedical engineering applications, claim the scientists.

German scientists have created a new technology that helps them print 3D objects with sound waves.

The design creates pressure fields using several acoustic holograms, which can be used to print solid particles, gel beads, and even living cells, according to the study released on Thursday.

Continue reading “This tech can print 3D objects with sound in ‘one-shot’ process” »

What’s next?

Increasingly it seems there is nothing that ChatGPT cannot do, even consulting judges in cases and boosting research. Now, the AI chatbot has been found to score at or around the approximately 60 percent passing threshold for the United States Medical Licensing Exam (USMLE), “with responses that make coherent, internal sense and contain frequent insights.”

This is according to a study published on Thursday in the open-access journal PLOS Digital Health.

Continue reading “Doctor ChatGPT? AI-bot almost passes the US Medical Licensing Exam” »